by Jon Rappoport May 1, 2019 (To join our email list, click here.) In a recent article, I explained how Bayer—with its $66 billion purchase of Monsanto—is “taking one for the team.” The team consists of several biotech giants. Its agenda? The reconfiguring of all life under the rubric of radical genetic manipulation. Bayer aims, … Continue reading Bayer and the ownership of all life